156 related articles for article (PubMed ID: 36099876)
21. Short hydration in chemotherapy containing cisplatin (≥75 mg/m2) for patients with lung cancer: a prospective study.
Horinouchi H; Kubota K; Itani H; Taniyama TK; Nakamichi S; Wakui H; Kanda S; Nokihara H; Yamamoto N; Sekine I; Tamura T
Jpn J Clin Oncol; 2013 Nov; 43(11):1105-9. PubMed ID: 24006505
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of 5-aminolevulinic acid in adult-onset Still's disease: A preclinical study in mice and a pilot study in humans.
Koga T; Sumiyoshi R; Tsuji Y; Kodama K; Endo Y; Furukawa K; Kawakami A
Clin Immunol; 2023 Dec; 257():109846. PubMed ID: 38007033
[TBL] [Abstract][Full Text] [Related]
23. 5-ALA/SFC Attenuated Binge Alcohol-Induced Gut Leakiness and Inflammatory Liver Disease in HIV Transgenic Rats.
Liu C; Zhu P; Fujino M; Zhu S; Ito H; Takahashi K; Nakajima M; Tanaka T; Zhuang J; Li XK
Alcohol Clin Exp Res; 2019 Aug; 43(8):1651-1661. PubMed ID: 31141180
[TBL] [Abstract][Full Text] [Related]
24. Combination of 5-aminolevulinic acid and iron prevents skin fibrosis in murine sclerodermatous graft-versus-host disease.
Liu C; Yang X; Zhu P; Fujino M; Ito H; Takahashi K; Nakajima M; Tanaka T; Wang J; Zhuang J; Zou H; Li XK
Exp Dermatol; 2018 Oct; 27(10):1104-1111. PubMed ID: 29978518
[TBL] [Abstract][Full Text] [Related]
25. 5-Aminolevulinic acid protects against cisplatin-induced nephrotoxicity without compromising the anticancer efficiency of cisplatin in rats in vitro and in vivo.
Terada Y; Inoue K; Matsumoto T; Ishihara M; Hamada K; Shimamura Y; Ogata K; Inoue K; Taniguchi Y; Horino T; Karashima T; Tamura K; Fukuhara H; Fujimoto S; Tsuda M; Shuin T
PLoS One; 2013; 8(12):e80850. PubMed ID: 24324635
[TBL] [Abstract][Full Text] [Related]
26. Short hydration regimen and nephrotoxicity of intermediate to high-dose cisplatin-based chemotherapy for outpatient treatment in lung cancer and mesothelioma.
Tiseo M; Martelli O; Mancuso A; Sormani MP; Bruzzi P; Di Salvia R; De Marinis F; Ardizzoni A
Tumori; 2007; 93(2):138-44. PubMed ID: 17557559
[TBL] [Abstract][Full Text] [Related]
27. Reappraisal of short-term low-volume hydration in cisplatin-based chemotherapy: results of a prospective feasibility study in advanced lung cancer in the Okayama Lung Cancer Study Group Trial 1002.
Hotta K; Takigawa N; Hisamoto-Sato A; Ichihara E; Kudo K; Uchida K; Yanase-Nakamura K; Tanaka H; Kato Y; Tabata M; Tanimoto M; Kiura K
Jpn J Clin Oncol; 2013 Nov; 43(11):1115-23. PubMed ID: 24082005
[TBL] [Abstract][Full Text] [Related]
28. A prospective study of oral 5-aminolevulinic acid to prevent adverse events in patients with localized prostate cancer undergoing low-dose-rate brachytherapy: Protocol of the AMBER study.
Miyake M; Tanaka N; Asakawa I; Yamaki K; Inoue T; Suzuki S; Hori S; Nakai Y; Anai S; Torimoto K; Toritsuka M; Nakagawa H; Tsukamoto S; Fujii T; Ohbayashi C; Hasegawa M; Kasahara M; Fujimoto K
Contemp Clin Trials Commun; 2020 Sep; 19():100593. PubMed ID: 32637724
[TBL] [Abstract][Full Text] [Related]
29. Sodium ferrous citrate and 5-aminolevulinic acid improve type 2 diabetes by maintaining muscle and mitochondrial health.
Kitamura N; Zhang S; Morel JD; Nagano U; Taworntawat T; Hosoda S; Nakamura A; Ogawa Y; Benegiamo G; Auwerx J; Tsubota K; Yokoyama Y; Watanabe M
Obesity (Silver Spring); 2023 Apr; 31(4):1038-1049. PubMed ID: 36823345
[TBL] [Abstract][Full Text] [Related]
30. Pilot Trial on the Effect of 5-Aminolevulinic Acid on Glucose Tolerance in Patients with Maternally Inherited Diabetes and Deafness.
Nakamura Y; Haraguchi A; Horie I; Kawakami A; Abiru N
Diabetes Ther; 2023 Feb; 14(2):447-459. PubMed ID: 36418716
[TBL] [Abstract][Full Text] [Related]
31. Short-term low-volume hydration in cisplatin-based chemotherapy for patients with lung cancer: the second prospective feasibility study in the Okayama Lung Cancer Study Group Trial 1201.
Ninomiya K; Hotta K; Hisamoto-Sato A; Ichihara E; Gotoda H; Morichika D; Tamura T; Kayatani H; Minami D; Kubo T; Tabata M; Tanimoto M; Kiura K
Int J Clin Oncol; 2016 Feb; 21(1):81-7. PubMed ID: 26093520
[TBL] [Abstract][Full Text] [Related]
32. Safety and efficacy of 5-aminolevulinic acid phosphate/iron in mild-to-moderate coronavirus disease 2019: A randomized exploratory phase II trial.
Tanaka T; Tashiro M; Ota K; Fujita A; Sawai T; Kadota J; Fukuda Y; Sumiyoshi M; Ide S; Tachikawa N; Fujii H; Hibino M; Shiomi H; Izumida M; Matsui K; Yamauchi M; Takahashi K; Yamanashi H; Sugimoto T; Akabame S; Umeda M; Shimizu M; Hosogaya N; Kosai K; Takeda K; Iwanaga N; Ashizawa N; Hirayama T; Takazono T; Yamamoto K; Imamura Y; Miyazaki T; Kobayashi Y; Ariyoshi K; Mukae H; Yanagihara K; Kita K; Izumikawa K
Medicine (Baltimore); 2023 Aug; 102(34):e34858. PubMed ID: 37653769
[TBL] [Abstract][Full Text] [Related]
33. The evaluation of urinary calprotectin levels for prediction of acute cisplatin-induced nephrotoxicity.
Koçak G; Bilik G; Yeşilova A; Oyman F; Can M; Cihan Ş
Medicine (Baltimore); 2022 Jul; 101(26):e29814. PubMed ID: 35777022
[TBL] [Abstract][Full Text] [Related]
34. 5-Aminolevulinic acid bypasses mitochondrial complex I deficiency and corrects physiological dysfunctions in Drosophila.
Nozawa N; Noguchi M; Shinno K; Saito T; Asada A; Ishii T; Takahashi K; Ishizuka M; Ando K
Hum Mol Genet; 2023 Aug; 32(16):2611-2622. PubMed ID: 37364055
[TBL] [Abstract][Full Text] [Related]
35. Dynamics of absorption, metabolism, and excretion of 5-aminolevulinic acid in human intestinal Caco-2 cells.
Saito K; Fujiwara T; Ota U; Hatta S; Ichikawa S; Kobayashi M; Okitsu Y; Fukuhara N; Onishi Y; Ishizuka M; Tanaka T; Harigae H
Biochem Biophys Rep; 2017 Sep; 11():105-111. PubMed ID: 28955775
[TBL] [Abstract][Full Text] [Related]
36. 5-aminolevulinic acid and sodium ferrous citrate decreased cell viability of gastric cancer cells by enhanced ROS generation through improving COX activity.
Suprihadi A; Pustimbara A; Ogura SI
Photodiagnosis Photodyn Ther; 2022 Dec; 40():103055. PubMed ID: 35934181
[TBL] [Abstract][Full Text] [Related]
37. Oral 5-aminolevulinic acid combined with sodium ferrous citrate prevents blood-aqueous barrier breakdown after anterior chamber paracentesis in healthy beagle dogs.
Otaka Y; Kanai K; Tomatsu A; Sangu R; Okada D; Nagai N; Yamashita Y; Ichikawa Y; Sakai A; Tajima K
J Vet Med Sci; 2023 Dec; 85(12):1257-1260. PubMed ID: 37880141
[TBL] [Abstract][Full Text] [Related]
38. 5-Aminolevulinic acid with ferrous iron induces permanent cardiac allograft acceptance in mice via induction of regulatory cells.
Hou J; Zhang Q; Fujino M; Cai S; Ito H; Takahashi K; Abe F; Nakajima M; Tanaka T; Xu J; Zou H; Ding Q; Li XK
J Heart Lung Transplant; 2015 Feb; 34(2):254-63. PubMed ID: 25455753
[TBL] [Abstract][Full Text] [Related]
39. Effects of 5-aminolevulinic acid with iron supplementation on respiratory responses to graded cycling and interval walking training achievement in older women over 75 yrs.
Ichihara Y; Masuki S; Uchida K; Takahashi K; Nakajima M; Nose H
Exp Gerontol; 2021 Jul; 150():111356. PubMed ID: 33864830
[TBL] [Abstract][Full Text] [Related]
40. 5-Aminolevulinic acid combined with sodium ferrous citrate mitigates effects of heat stress on bovine oocyte developmental competence.
Elgendy O; Kitahara G; Taniguchi S; Osawa T
J Reprod Dev; 2022 Aug; 68(4):271-277. PubMed ID: 35705297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
